WO1999053917A1
(en)
*
|
1998-04-21 |
1999-10-28 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Cannabinoids as antioxidants and neuroprotectants
|
US6566560B2
(en)
|
1999-03-22 |
2003-05-20 |
Immugen Pharmaceuticals, Inc. |
Resorcinolic compounds
|
EP1189603A2
(de)
|
1999-03-22 |
2002-03-27 |
Immugen Pharmaceuticals, Inc. |
Behandlung von immunerkrankungen wie hiv-erkrankung und neoplastischen erkrankungen
|
AU6088200A
(en)
*
|
1999-07-12 |
2001-01-30 |
Virginia Commonwealth University |
Novel vasodilator cannabinoid analogs
|
US8449908B2
(en)
|
2000-12-22 |
2013-05-28 |
Alltranz, Llc |
Transdermal delivery of cannabidiol
|
CA2438097C
(en)
*
|
2001-02-14 |
2006-04-25 |
Gw Pharma Limited |
Cannabinoids pharmaceutical formulations
|
WO2002064169A1
(fr)
*
|
2001-02-16 |
2002-08-22 |
Daiichi Suntory Pharma Co., Ltd. |
Procedes de traitement de maladies en association avec la diminution de l'expression du gene aop-1 ou de aop-1 et remedes conçus pour ces maladies
|
GB2377218A
(en)
*
|
2001-05-04 |
2003-01-08 |
Gw Pharmaceuticals Ltd |
Process and apparatus for extraction of active substances and enriched extracts from natural products
|
AU2002331595A1
(en)
*
|
2001-08-15 |
2003-03-03 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of |
Novel vasoconstrictor cannabinoid analogs
|
US6825209B2
(en)
|
2002-04-15 |
2004-11-30 |
Research Triangle Institute |
Compounds having unique CB1 receptor binding selectivity and methods for their production and use
|
US7285687B2
(en)
*
|
2002-04-25 |
2007-10-23 |
Virginia Commonwealth University |
Cannabinoids
|
US20060160776A1
(en)
*
|
2003-05-28 |
2006-07-20 |
Pharmacia Corporation |
Compositions of a cyclooxygenase-2 selective inhibitor and a cannabinoid agent for the treatment of central nervous system damage
|
IL157849A0
(en)
*
|
2003-09-10 |
2004-03-28 |
Yissum Res Dev Co |
Pharmaceutical compositions containing (+) cannabidiol and derivatives thereof and some such novel derivatives
|
US20060160748A1
(en)
*
|
2003-11-25 |
2006-07-20 |
Shey-Shing Sheu |
Compounds for delivering amino acids or peptides with antioxidant activity into mitochondria and use thereof
|
IL160420A0
(en)
|
2004-02-16 |
2004-07-25 |
Yissum Res Dev Co |
Treating or preventing diabetes with cannabidiol
|
JP4569142B2
(ja)
*
|
2004-03-22 |
2010-10-27 |
コニカミノルタホールディングス株式会社 |
表示素子
|
US20080262079A1
(en)
*
|
2004-08-09 |
2008-10-23 |
Bernard Mach |
Cannabinoid Compositions and Methods of Use Thereof
|
WO2006063109A2
(en)
*
|
2004-12-09 |
2006-06-15 |
Insys Therapeutics, Inc. |
Room-temperature stable dronabinol formulations
|
US7597910B2
(en)
*
|
2005-08-20 |
2009-10-06 |
Slgm Medical Research Institute |
Compositions and methods for treating prostate disorders
|
CA2623723A1
(en)
*
|
2005-09-29 |
2007-04-12 |
Amr Technology, Inc. |
Process for production of delta-9-tetrahydrocannabinol
|
WO2007105210A2
(en)
*
|
2006-03-13 |
2007-09-20 |
Hadasit Medical Research Services & Development Limited |
Therapeutic uses of cannabidiol compounds
|
NZ573217A
(en)
|
2006-05-05 |
2011-11-25 |
Plascoenergy Ip Holdings S L Bilbao Schaffhausen Branch |
A facility for conversion of carbonaceous feedstock into a reformulated syngas containing CO and H2
|
GB2438682A
(en)
*
|
2006-06-01 |
2007-12-05 |
Gw Pharma Ltd |
New use for cannabinoids
|
AU2007256564A1
(en)
*
|
2006-06-08 |
2007-12-13 |
Neurokey A/S |
Use of cannabinoid receptor agonists as hypothermia inducing drugs for the treatment of ischemia
|
US20080112895A1
(en)
*
|
2006-08-04 |
2008-05-15 |
Insys Therapeutics Inc. |
Aqueous dronabinol formulations
|
US9763894B2
(en)
*
|
2006-12-05 |
2017-09-19 |
Virginia Commonwealth University |
Inflammation therapy
|
WO2008107879A1
(en)
*
|
2007-03-05 |
2008-09-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Novel cannabidiol derivatives and their use as anti-inflammatory agents
|
US8242178B2
(en)
*
|
2007-06-18 |
2012-08-14 |
University Of South Carolina |
Use of cannabidiol in the treatment of autoimmune hepatitis
|
GB2451254A
(en)
*
|
2007-07-24 |
2009-01-28 |
Gw Pharma Ltd |
Cannabidiol for use in the treatment of neurodegenerative conditions
|
EP2176208B1
(de)
*
|
2007-07-30 |
2015-01-21 |
Zynerba Pharmaceuticals, Inc. |
Prodgrugs von cannabidiol, zusammensetzungen mit prodgrugs von cannabidiol und verfahren zu ihrer verwendung
|
WO2009020666A1
(en)
*
|
2007-08-06 |
2009-02-12 |
Insys Therapeutics Inc. |
Oral cannabinoid liquid formulations and methods of treatment
|
EP2341903A1
(de)
*
|
2008-07-31 |
2011-07-13 |
Bionorica Research GmbH |
Cannabinoide zur behandlung oder prävention von kognitiver beeinträchtigung und demenz
|
US10105343B2
(en)
|
2010-04-30 |
2018-10-23 |
Kubby Patent And Licenses, Limited Liability Company |
Cannabis based compositions and methods of treating hypertension
|
KR101196354B1
(ko)
*
|
2010-09-03 |
2012-11-01 |
서유헌 |
퇴행성 신경계 뇌 질환의 예방 또는 치료용 약학 조성물
|
US8642645B2
(en)
|
2011-05-20 |
2014-02-04 |
Brooks Kelly Research, LLC. |
Pharmaceutical composition comprising Cannabinoids
|
CA2895805A1
(en)
|
2012-12-18 |
2014-06-26 |
Kotzker Consulting Llc |
Use of cannabinoids and terpenes for treatment of organophosphate and carbamate toxicity
|
EP2968368B1
(de)
|
2013-03-15 |
2017-08-09 |
Glia LLC |
Kraniale abgabe von arzneimitteln
|
US10441617B2
(en)
|
2013-03-15 |
2019-10-15 |
Biotech Institute, Llc |
Breeding, production, processing and use of medical cannabis
|
US9095554B2
(en)
|
2013-03-15 |
2015-08-04 |
Biotech Institute LLC |
Breeding, production, processing and use of specialty cannabis
|
WO2014200350A1
(en)
|
2013-06-13 |
2014-12-18 |
Cannabis Science International Holding B.V. |
Composition for the treatment of neurobehavioral disorders
|
EP3049076A4
(de)
|
2013-09-26 |
2018-04-18 |
Ronald D. Sekura |
Topische behandlungen mit einem aus cannabis sp. gewonnenen pflanzlichen arzneimittel
|
CA3090957A1
(en)
|
2013-10-29 |
2015-05-07 |
Biotech Institute, Llc |
Breeding, production, processing and use of specialty cannabis
|
US9380813B2
(en)
|
2014-02-11 |
2016-07-05 |
Timothy McCullough |
Drug delivery system and method
|
US10821240B2
(en)
|
2014-02-11 |
2020-11-03 |
Vapor Cartridge Technology Llc |
Methods and drug delivery devices using cannabis
|
US9220294B2
(en)
|
2014-02-11 |
2015-12-29 |
Timothy McCullough |
Methods and devices using cannabis vapors
|
US10653787B2
(en)
|
2014-03-18 |
2020-05-19 |
Izun Pharmaceuticals Corp |
Water-based cannabinoid and opioid compositions
|
US10610512B2
(en)
|
2014-06-26 |
2020-04-07 |
Island Breeze Systems Ca, Llc |
MDI related products and methods of use
|
GB2527599A
(en)
*
|
2014-06-27 |
2015-12-30 |
Gw Pharma Ltd |
Use of 7-OH-Cannabidiol (7-OH-CBD) and/or 7-OH-Cannabidivarin (7-OH-CBDV) in the treatment of epilepsy
|
US9822384B2
(en)
|
2014-07-14 |
2017-11-21 |
Librede Inc. |
Production of cannabinoids in yeast
|
US9565865B2
(en)
|
2014-08-15 |
2017-02-14 |
Imbue LLC |
Method for making coffee products containing cannabis ingredients
|
US10897915B2
(en)
|
2014-08-15 |
2021-01-26 |
Blacklist Holdings, Inc. |
Method for making coffee products containing cannabis ingredients
|
WO2016054268A1
(en)
|
2014-09-30 |
2016-04-07 |
MJAR Holdings, LLC |
Methods of growing cannabaceae plants using artificial lighting
|
GB2531282A
(en)
*
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabinoids in the treatment of epilepsy
|
CA2965493C
(en)
|
2014-10-21 |
2021-12-07 |
United Cannabis Corp. |
Cannabis extracts and methods of preparing and using same
|
US9539295B2
(en)
|
2014-12-05 |
2017-01-10 |
Bradley Michael Bohus |
Cannabidiol (CBD) enriched alcohol
|
WO2016105514A1
(en)
|
2014-12-23 |
2016-06-30 |
Biotech Institute, Llc |
A reliable and robust method for the analysis of cannabinoids and terpenes in cannabis
|
MA41299A
(fr)
|
2014-12-30 |
2017-11-07 |
Axim Biotechnologies Inc |
Solutions ophtalmiques pour le traitement du glaucome et de la conjonctivite
|
US10830780B2
(en)
|
2015-01-26 |
2020-11-10 |
Biotech Institute, Llc |
Apparatus and methods for sample analysis and classification based on terpenes and cannabinoids in the sample
|
US20160298151A1
(en)
|
2015-04-09 |
2016-10-13 |
Sher Ali Butt |
Novel Method for the cheap, efficient, and effective production of pharmaceutical and therapeutic api's intermediates, and final products
|
US10934554B2
(en)
|
2015-05-28 |
2021-03-02 |
Tweed, Inc. |
Cannabis plants having modified expression of THCA synthase
|
JP2018534362A
(ja)
*
|
2015-10-16 |
2018-11-22 |
スキティアン バイオサイエンシーズ インコーポレーテッドScythian Biosciences Inc. |
外傷性脳損傷を処置するための方法および組成物
|
EP3442953A1
(de)
*
|
2016-04-15 |
2019-02-20 |
Teewinot Technologies Limited |
Biosynthese von cannabinoiden prodrugs
|
US10499584B2
(en)
|
2016-05-27 |
2019-12-10 |
New West Genetics |
Industrial hemp Cannabis cultivars and seeds with stable cannabinoid profiles
|
EP3471745A4
(de)
|
2016-06-15 |
2020-01-22 |
Ojai Energetics PBC |
Verfahren und zusammensetzungen zur reduzierung von oxidativem stress
|
WO2018035030A1
(en)
*
|
2016-08-15 |
2018-02-22 |
Corr-Jensen Inc. |
Time release fat-soluble actives
|
CA3077624A1
(en)
*
|
2016-10-01 |
2018-04-05 |
James Smeeding |
Pharmaceutical compositions comprising a statin and a cannabinoid and uses thereof
|
WO2018125857A1
(en)
|
2016-12-30 |
2018-07-05 |
X Traxion, Llc |
Extraction of compounds from cannabis
|
US10960322B2
(en)
|
2018-07-02 |
2021-03-30 |
Pratt Bethers |
Apparatus for purifying crystals using solvent vapors
|
US10308626B1
(en)
|
2018-07-02 |
2019-06-04 |
Pratt Bethers |
Crystal purification in a glass or metal container
|
US10561693B2
(en)
|
2017-09-01 |
2020-02-18 |
MariJ Pharmaceuticals, Inc. |
Cultivation, processing, and synthesis of cannabidiols
|
EP3453397A1
(de)
|
2017-09-12 |
2019-03-13 |
Albert Jan Dijkstra |
Verfahren zur isolierung eines cannabinoidextrakts und produkt aus cannabispflanzenmaterial
|
US10688191B2
(en)
|
2018-01-19 |
2020-06-23 |
Hr Biomed, Llc |
Delivery of a chemotherapy agent across the blood-brain barrier
|
CA3110198A1
(en)
*
|
2018-08-20 |
2020-02-27 |
Bessor Pharma, Llc |
Novel cannabinoids and cannabinoid acids and their derivatives
|
US11026888B1
(en)
|
2019-01-04 |
2021-06-08 |
Nutrition Therapeutics, Inc. |
Functional beverage compositions and methods of using and making same
|
WO2020180960A1
(en)
*
|
2019-03-04 |
2020-09-10 |
University Of Florida Research Foundation, Inc. |
Methods and compositions for substituted axially-chiral cannabinol analogs
|
JP2022532116A
(ja)
|
2019-05-06 |
2022-07-13 |
ザ ユニバーシティ オブ ブリティッシュ コロンビア |
抗生物質カンナビノイド-テルペン製剤
|
EP3997069A4
(de)
*
|
2019-07-12 |
2023-07-12 |
Canopy Growth Corporation |
Cannabinoidderivate
|
WO2021055079A1
(en)
|
2019-09-16 |
2021-03-25 |
Vapor Cartridge Technology Llc |
Drug delivery system with stackable substrates
|
GB201916974D0
(en)
*
|
2019-11-21 |
2020-01-08 |
Gw Res Ltd |
Cannabidol-type cannabinoid compound
|
GB201916977D0
(en)
|
2019-11-21 |
2020-01-08 |
Gw Res Ltd |
Cannibidol-type cannabinoid compound
|
US11590187B2
(en)
*
|
2020-01-14 |
2023-02-28 |
Shaman Naturals, Llc |
Antimicrobial compositions
|
CA3074150A1
(en)
|
2020-02-18 |
2021-08-18 |
Ovation Science, Inc. |
Composition and method for transdermal delivery of cannabidiol (cbd) and delta9-tetrahydrocannabinol (thc)
|
EP4161900A1
(de)
*
|
2020-06-03 |
2023-04-12 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Cannabidiolsäure (cbda)-derivate und verwendungen davon
|
GB2597302A
(en)
*
|
2020-07-20 |
2022-01-26 |
Gw Res Ltd |
Use of cannabidiol in the treatment of seizures associated with stroke or brain haemorrhage
|
AU2021318553A1
(en)
|
2020-07-28 |
2023-03-23 |
Impello Biosciences Inc. |
Methods and compositions for altering secondary metabolites in plants
|
AU2021386606A1
(en)
|
2020-11-24 |
2023-06-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Cannabinoid derivatives and their use for the treatment of inflammation and/or pain and/or obesity
|
CN112516119A
(zh)
*
|
2021-02-05 |
2021-03-19 |
云南维他源生物科技有限公司 |
一种治疗脑卒中的asbd药物组合物及其制剂与应用
|
WO2022238701A1
(en)
*
|
2021-05-12 |
2022-11-17 |
GW Research Limited |
Resorcinol derivative as a pharmaceutically active compound and method of preparation thereof
|
CN117396455A
(zh)
*
|
2021-05-12 |
2024-01-12 |
吉伟研究有限公司 |
间苯二酚、其制造方法及其用途
|
WO2023285072A1
(en)
|
2021-07-13 |
2023-01-19 |
Receptorpharma Inc S-Corp |
Esters of 7-cooh cbd derivatives and their use as prevention, prophylaxis of progression, and/or treatment of neurogenerative diseases.
|
CN113735709B
(zh)
*
|
2021-09-17 |
2022-03-18 |
中国农业科学院农产品加工研究所 |
一种大麻二酚-2-丁酸酯及其应用
|
CN116253700A
(zh)
*
|
2021-12-10 |
2023-06-13 |
德义制药有限公司 |
一种大麻二酚衍生物及其制备方法和应用
|